Cardiac ablation

2 clinical trials

Quick filters

Clinical trials for Cardiac ablation

2 trials across Europe

See all trials →

Quick filters

2 Clinical trials

Cardiac ablation

Recruiting

Study on Early Treatment of Persistent Atrial Fibrillation: Comparing Cryoballoon Therapy with Dronedarone, Flecainide, Sotalol, and Propafenone in Symptomatic Patients

Registered drugNo placebo

Study on Early Treatment of Persistent Atrial Fibrillation: Comparing Cryoballoon Therapy with Dronedarone, Flecainide, Sotalol, and Propafenone in Symptomatic Patients

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Dronedarone
Sponsor:Gottsegen National Cardiovascular Center

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Study on Long-Term Anticoagulation with Rivaroxaban vs. Acetylsalicylic Acid for Patients at Risk of Stroke After Atrial Fibrillation Ablation

Registered drugNo placebo

Study on Long-Term Anticoagulation with Rivaroxaban vs. Acetylsalicylic Acid for Patients at Risk of Stroke After Atrial Fibrillation Ablation

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:University Of Ottawa Heart Institute

Contact Research Centre

See all trials →

Cardiac ablation

Clinical trials for Cardiac ablation

Cardiac ablation

Study on Early Treatment of Persistent Atrial Fibrillation: Comparing Cryoballoon Therapy with Dronedarone, Flecainide, Sotalol, and Propafenone in Symptomatic Patients

Atrial fibrillation+2

Study on Long-Term Anticoagulation with Rivaroxaban vs. Acetylsalicylic Acid for Patients at Risk of Stroke After Atrial Fibrillation Ablation

Filter the trials

Prefer not to search? Our Concierge searches the trials for you.